UPDATE : Monday, October 21, 2019
상단여백
Researchers discover spreading probability of wet macular degeneration
A study conducted by a local research team has revealed the transmission pr...
by Lee Han-soo  |  2019-09-26 14:23
라인
Ranitidine heartburn drugs banned due to carcinogen risk
The Ministry of Food and Drug Safety has suspended the manufacturing and se...
by Lee Hye-seon  |  2019-09-26 13:32
라인
Pfizer’s leukemia therapy Besponsa to get insurance benefit
The government said it would grant insurance benefit to Pfizer’s leukemia t...
by Kim Yun-mi  |  2019-09-26 11:26
라인
'Xtandi emerges as convenient treatment option for prostate cancer patients'
Astellas Korea is strengthening its position in the local prostate cancer m...
by Lee Han-soo  |  2019-09-25 17:39
라인
Korea, Uzbekistan speed up public health cooperation
Korea will accelerate cooperation with Uzbekistan in public health, initiat...
by Kwak Sung-sun  |  2019-09-25 15:26
라인
Ministry to announce results of ranitidine testing for carcinogen
The government is likely to announce the results of the test on ranitidine ...
by Lee Hye-seon  |  2019-09-25 14:46
라인
Helixmith blames hospital for absurd drug mix-up
Helixmith used to be one of the promising biotech firms with its market cap...
by Jeong Sae-im  |  2019-09-25 13:42
라인
NCC develops new chemotherapy to increase survival of osteosarcoma patients
A research team at the National Cancer Center has developed new chemotherap...
by Lee Han-soo  |  2019-09-25 11:48
라인
Court rejects Kolon’s appeal over Invossa license revocation
A Seoul court turned down Kolon Life Science’s appeal for stopping the gove...
by Jeong Sae-im  |  2019-09-25 11:18
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment
Huons said that it has signed an exclusive licensing agreement for developi...
by Lee Han-soo  |  2019-09-25 11:18
라인
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
AstraZeneca announced detailed results of the landmark phase 3 DAPA-HF tria...
by Lee Han-soo  |  2019-09-24 18:08
라인
Qurient enrolls patients for trials of atopy treatment
Qurient said Tuesday that it has completed patient enrollment for phase 2b ...
by Lee Han-soo  |  2019-09-24 17:00
라인
Hanmi’s US partner to unveil results of anticancer drug study
Hanmi Pharmaceutical said that Athenex, its U.S. partner, plans to present ...
by Lee Han-soo  |  2019-09-24 17:00
라인
Thyroidectomy ups depression risk by 1.81 folds within 2 months
Patients who undergo thyroidectomy face a steep increase in depression risk...
by Kim Eun-young  |  2019-09-24 17:00
라인
Why using end-to-end services should be part of a drug product strategy
Specialized services offered by end-to-end service providers are essential ...
by Lee Han-soo  |  2019-09-24 16:54
라인
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment
Helixmith said that it has failed to make conclusions due to data contamina...
by Lee Han-soo  |  2019-09-24 16:38
라인
KMA advises doctors to avoid ranitidine in heartburn treatment
After the U.S. regulator found potentially cancer-causing chemical N-Nitros...
by Choi Gwang-seok  |  2019-09-24 14:40
라인
How does GE Healthcare use AI for product development?
GE Healthcare drew keen attention by unveiling Edison, an intelligence plat...
by Park Gi-taek  |  2019-09-24 12:42
라인
Dog dewormer gets scarce amid rumors of efficacy in cancer
Korean cancer patients are rushing to pharmacies to buy fenbendazole, a dog...
by Lee Han-soo  |  2019-09-24 12:41
라인
Hwail, SupexBNP wins patent for neutropenia treatment in US
Hwail Pharmaceutical and SupexBNP said that they have registered a patent f...
by Lee Han-soo  |  2019-09-23 22:34
여백
여백
여백
Back to Top